20 – 21 September 2016
Marina Bay Sands, Singapore, Singapore

Meet the Speakers

Speaker


Herve Le Louet
Herve Le Louet
Member for the European Commission of the Pharmacovigilance Risk Assessment
European Medicines Agency
Siti Asfijah Abdoellah
Siti Asfijah Abdoellah
Head, Sub-Directorate of Surveillance and Risk Analysis of Therapeutic Prod
Indonesia National Agency of Drug and Food Control (NADFAC)
Noraisyah Mohd Sani
Noraisyah Mohd Sani
Head of Pharmacovigilance Section
National Pharmaceutical Regulatory Agency (NPRA), Malaysia (formerly known as National Pharmaceutical Control Bureau)
Wimon Suwankesawong
Wimon Suwankesawong
Head of Health Product Vigilance Center
Thailand FDA
Nguyen Hoang Anh
Nguyen Hoang Anh
Technical Vice Director
Vietnam National Centre for Drug Information and ADR Monitoring
Christine Chandran
Christine Chandran
Country Safety Team Lead
Johnson & Johnson
Minhaj Obeidullah
Minhaj Obeidullah
Regional Head Pharmacovigilance Oversight - APAC
Sandoz
Jessica Thongcharen
Jessica Thongcharen
Associate Director, Global Pharmacovigilance Operations,
Takeda Global Research & Development Center Asia Private Limited
Jean Christophe Delumeau
Jean Christophe Delumeau
Head of Pharmacovigilance Asia Pacific & China
Bayer South-East Asia (Singapore)
Deepa Arora
Deepa Arora
‎Vice President- Pharmacovigilance & Global Head
Lupin
E Stewart Geary
E Stewart Geary
Chief Medical Officer, Vice President and General Manager
Eisai Co., Ltd.
Byron Webb
Byron Webb
Local Safety Responsible
Roche, (Philippines) Inc.
Rie Matsui
Rie Matsui
Director, Regional Labeling Head for Asia
Pfizer
Kevin Yap
Kevin Yap
Professor, Lecturer
National University of Singapore
Sushrut Bhatt
Sushrut Bhatt
Director Medical Governance Quality & Risk Management
GlaxoSmithKline Pharmaceuticals Limited
Jamal Baig
Jamal Baig
Associate Director of Pharmacovigilance
Merck Sharp And Dohme (MSD)
Miguel Orri
Miguel Orri
Managing Director
InnovatOrri Pharma Consulting